financetom
Business
financetom
/
Business
/
Lifeloc Technologies Insider Bought Shares Worth $296,617, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lifeloc Technologies Insider Bought Shares Worth $296,617, According to a Recent SEC Filing
Jul 26, 2024 4:52 AM

07:24 AM EDT, 07/26/2024 (MT Newswires) -- Donald E. Siecke, Director, on July 23, 2024, executed a purchase for 78,057 shares in Lifeloc Technologies ( LCTC ) for $296,617. Following the Form 4 filing with the SEC, Siecke has control over a total of 538,352 shares of the company, with 538,352 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1493137/000107997324001108/xslF345X03/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Match Q2 Net Earnings Rise, Revenue Decreases
Match Q2 Net Earnings Rise, Revenue Decreases
Aug 5, 2025
04:49 PM EDT, 08/05/2025 (MT Newswires) -- Match (MTCH) reported Q2 net earnings Tuesday of $0.49 per diluted share, up from $0.48 a year earlier. Analysts polled by FactSet expected $0.49. Revenue for the quarter ended June 30 was $863.7 million, down from $864.1 million a year earlier. Analysts surveyed by FactSet expected $854.1 million. The company expects Q3 revenue...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Jazz Pharmaceuticals Q2 Swings to Non-GAAP Loss, Revenue Rises; Updates 2025 Guidance
Jazz Pharmaceuticals Q2 Swings to Non-GAAP Loss, Revenue Rises; Updates 2025 Guidance
Aug 5, 2025
04:49 PM EDT, 08/05/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) reported a Q2 non-GAAP loss late Tuesday of $8.25 per diluted share, swinging from earnings of $5.25 a year ago. Analysts polled by FactSet expected a loss of $7.61. Revenue for the quarter ended June 30 was $1.05 billion, up from $1.02 billion a year earlier. Analysts surveyed...
Innovex International Q2 revenue misses analyst estimates
Innovex International Q2 revenue misses analyst estimates
Aug 5, 2025
Overview * Innovex ( INVX ) Q2 revenue falls 7% qtr/qtr, missing analyst expectations * Adjusted EBITDA for Q2 beats analyst estimates, reflecting strong profitability Outlook * Innovex expects Q3 2025 revenue of $230 - $240 mln * Company anticipates Q3 2025 Adjusted EBITDA of $40 - $45 mln Result Drivers * CITADEL ACQUISITION - Acquisition of Citadel Casing Solutions...
Copyright 2023-2026 - www.financetom.com All Rights Reserved